Security Snapshot

Semnur Pharmaceuticals, Inc. - Common Stock, par value $0.0001 (SMNRW) Institutional Ownership

CUSIP: 81686G113

13F Institutional Holders and Ownership History

13F reference period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$0.01

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
230,209,400
SEC-reported price per share
$0.01
Filing notes and source

Key facts

  • SMNRW - Semnur Pharmaceuticals, Inc. - Common Stock, par value $0.0001 is tracked under CUSIP 81686G113.
  • 13F reference-period holder data is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder data for the Q2 2026 reference period is not available.
  • Available periods remain in the history table; they do not substitute for the headline period.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

81686G113

13F reference period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
SMNRW
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Scilex Holding Co 79% -3.9% $1,815,201 -$70,347 181,520,112 -3.7% Scilex Holding Company 15 Jun 2026
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .